Editas Medicine Announces First Quarter 2019 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/29/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- BioNTech ends colorectal cancer mRNA therapy trial early
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Pinterest CFO resigns, interim replacement named
Editas Medicine (EDIT) Reports Q1 Loss of $0.60
May 7, 2019 4:38 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q1 EPS of ($0.60), versus $0.67 reported last year. Revenue for the quarter came in at $2.07 million, versus $3.93 million reported last year.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More